UK small-cap RNS · 5 Oct 2026
Every announcement of UK small & mid caps under £2bn. The ones that started or moved a situation are marked – a click opens it.
| Date | Company | Mcap | Holder | Stake | Crossed | |
|---|---|---|---|---|---|---|
| 5 Oct | Workspace Group WKP | £637m | Saba Capital Management, L.P. | 29.73% → 29.73% | ||
| 5 Oct | Renalytix RENX | £40m | Heights Capital Management, Inc. | 14.76% → 12.84% | ||
| 5 Oct | DLN DLN | – | Norges Bank | 7.34% → 4.43% | 5% | |
| 5 Oct | Victrex plc VCT | £777m | Norges Bank | 9.18% → 9.18% | ||
| 5 Oct | Applied Nutrition Plc APN | £735m | UBS Group AG-Investment Bank & Global Wealth Management | 5.25% → 0% | 5% | |
| 5 Oct | Cambridge Nutritional Science CNSL | £3.7m | Spreadex LTD | 9.12% → 8.29% |
Notifications of major holdings (TR-1): a holder crossing 3%, 5%, 10% … of the voting rights. Key shows stakes of 5% and more; the 3–5% band (mostly index funds) is under All. Transfers inside a group are left out.